2025/05/31 by A.B. Nadraga, Olena Kornіychuk, Melaniia-Iryna Nadraga · 1 voice
Immunology and Microbiology · Mathematics · Medicine · #Antibiotic Use and Resistance #COVID-19 epidemiological studies #Clostridium difficile and Clostridium perfringens research
paper · pdf · doi:10.21802/e-gmj2025-a15
openalex publication_date 2025/05/31 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/07
Epidemic seasons of respiratory infections during the COVID-19 pandemic have been marked by the simultaneous circulation of multiple pathogens capable of infecting the human body. Investigating the altered pathogenicity of coexisting microorganisms and their influence on disease progression provides valuable insights for the development of effective therapeutic and preventive strategies against infectious processes. This article provides a comprehensive review of current literature on viral-bacterial interactions in the context of respiratory infections, their pathogenic mechanisms, and significance during the COVID-19 pandemic. It synthesizes recent findings on how SARS-CoV-2 influences mucosal immunity, facilitates secondary bacterial infections through immune modulation, and impacts disease severity and clinical outcomes in co-infected individuals. Special attention is given to the molecular and cellular pathways mediating virus-bacteria interactions, including host receptor modulation, cytokine and interferon response alterations, and disruptions to the respiratory and gastrointestinal microbiota. The epidemiological trends observed during the COVID-19 pandemic, including shifts in the prevalence of common respiratory pathogens and the emergence of new co-infection patterns, are also considered. Understanding the dynamic interplay between viral and bacterial pathogens is crucial for optimizing patient management, improving outcomes, and guiding effective public health interventions.